Kirti Rani et al, IJCPS, 2016, 4(3): 115–117 International Journal of Chemistry and Pharm Interna P Journal Ho Research Article Synthesis of Egg Albumin Na Modified Emulso-Desolvation Kirti Rani* Amity Institute of Biotechnology, Amity Uni A B S T R A C T Egg albumin nanoparticles (EANPs) are p improved targeted delivery. EANPs are a capacity to load desired drug with high site controlling of EANPs was also done by u controlled and sustained targeted delivery Nanotechnology Albumin Binding Techno toluene driven modified emuslo-desolvation Light Scatting) was assigned to characterize attained size ranging from 0.5 nm to 11 n observed to attained narrow size distribution be used as safe and low-cost nanopractice potent drug and gene delivery as nonviral n considered in the field of regenerative medic Keywords: Egg albumin nanoparticles; EA A R T I C L E I N F O CONTENTS 1. Introduction . . . . . . . . . . . . . . . . . . 2. Experimental. . . . . . . . . . . . . . . . . . 3. Results and Discussion. . . . . . . . . . 4. Conclusion . . . . . . . . . . . . . . . . . . . 5. References . . . . . . . . . . . . . . . . . . . Article History: Received 21 January 2016 Citation: Kirti Rani, et al. Synthesis of Egg A Method. Int. J. Chem, Pharm, Sci., 2016, 4(3): 11 Copyright© 2016 Kirti Rani, et al. This is an op which permits unrestricted use, distribution and r *Corresponding Author Kirti Rani Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Sec-125, Noida-201303, U.P, India. Manuscript ID: IJCPS2883 CODEN (USA): IJ maceutical Sciences ational Journal of Chemistry and Pharmaceutical Sciences ome Page: www.pharmaresearchlibrary.com/ijcps anoparticles (EANPs) by Using Toluene n Method iversity Uttar Pradesh, Noida, Sec-125, Noida-201303, U. previously reported a safe and biocompatible drug carri also low-cost and safe nanomaterials to carry out mor specificity and low cytotoxicity and desired delivery rate using various methods to make them more potent nonvi of the respective biological and chemical components ology (nab technology). In this designed work, EANPs n method to achieve more controllable particle size at na e the size distribution of the prepared EANPs. The prepare nm with exhibited diameter up to 365.8 nm and width n at nanoscale considerations. Hence, this toluene-butanol e to prepare nanosized EANPs that may further employ nano-therapeutic vehicles in various therapeutic applicatio cine, molecular medicine and nanomedicine. ANPs; Emulso-Desolvation; Toluene; Dynamic Light Scatt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6, Accepted 24 February 2016, Available Online 27 Mar Albumin Nanoparticles (EANPs) by Using Toluene Driven Mo 15-117. pen-access article distributed under the terms of the Creative Com reproduction in any medium, provided the original work is prop JCPNH | ISSN: 2321-3132 115 Open Access e Driven .P, India. ier systems to carry out re efficient drug loading e at the targeted site. Size iral carriers to carry out that bind in to them by were prepared by using anoscale. DLS (Dynamic ed EANPs were found to of 60.50 nm which are l desolvation method can yed to carry out safe and ons which are going to be tering (DLS) . . . . . . . . . . . . . . . . . .49 . . . . . . . . . . . . . . . . . 49 . . . . . . . . . . . . . . . . . 49 . . . . . . . . . . . . . . . . . .50 . . . . . . . . . . . . . . . . . 50 rch 2016 PAPER-QR CODE odified Emulso-Desolvation mmons Attribution License, perly cited.